| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/2007 | US20070020246 Use of microchimeric cells in the treatment of malignancy |
| 01/25/2007 | US20070020244 Fiber constructs and process of fiber fabrication |
| 01/25/2007 | US20070020234 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
| 01/25/2007 | US20070020233 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease |
| 01/25/2007 | US20070020232 Compositions and methods for cancer immunotherapy |
| 01/25/2007 | US20070020227 Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| 01/25/2007 | US20070020196 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| 01/25/2007 | US20070020192 Delivery of therapeutics conjugated to neonatal Fc receptor (FcRn) binding partner to intestinal, mucosal epithelium and epithelium of the lung; elicit immune response; systemic delivery of an interferon across an epithelial barrier |
| 01/25/2007 | US20070020179 Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof |
| 01/25/2007 | CA2854576A1 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | CA2636367A1 Method to inhibit proliferation and growth of metastases |
| 01/25/2007 | CA2616256A1 Genetically modified antibody composition |
| 01/25/2007 | CA2616005A1 Beta-glucuronide-linker drug conjugates |
| 01/25/2007 | CA2615846A1 Potency assays for antibody drug substance binding to an fc receptor |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615738A1 Bifunctional protein anchors |
| 01/25/2007 | CA2615658A1 Recombinant flu vaccines |
| 01/25/2007 | CA2615468A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 01/25/2007 | CA2615389A1 Lawsonia vaccine and methods of use thereof |
| 01/25/2007 | CA2615386A1 Catalytic immunoglobulins |
| 01/25/2007 | CA2615328A1 Highly sensitive immunoassays and antibodies for detection of blood factor viii |
| 01/25/2007 | CA2614972A1 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | CA2614322A1 Paramyxoviridae virus preparations |
| 01/25/2007 | CA2613778A1 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1746162A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1746107A2 Antibody variants and fragments thereof |
| 01/24/2007 | EP1746106A2 Use of TACI as an anti-tumor agent |
| 01/24/2007 | EP1746103A1 Bifunctional protein anchors |
| 01/24/2007 | EP1746102A1 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745798A2 Hcv vaccine compositions |
| 01/24/2007 | EP1745797A2 Vascularization inhibitors |
| 01/24/2007 | EP1745077A2 Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 01/24/2007 | EP1745076A2 Antibodies specific for glycoprotein vi and methods of producing these antibodies |
| 01/24/2007 | EP1745075A2 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof |
| 01/24/2007 | EP1745067A2 Polypeptides from non-typeable haemophilus influenzae |
| 01/24/2007 | EP1744780A2 Cancer treatment using viruses and camptothecins |
| 01/24/2007 | EP1744779A2 Lytic enzymes and spore surface antigen for detection and treatment of "bacillus anthracis" bacteria and spores |
| 01/24/2007 | EP1744734A2 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| 01/24/2007 | EP1575612B1 Immunogenic composition |
| 01/24/2007 | EP1487497B1 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1383795B1 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/24/2007 | EP1374901B1 Graft rejection suppressors |
| 01/24/2007 | EP1276501B9 Method for treatment of tumors using photodynamic therapy |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1180525B1 Transcriptional activation inhibitory protein |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | EP1049712B1 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/24/2007 | EP1032674B1 (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/24/2007 | EP1032416B1 Neospora vaccines |
| 01/24/2007 | EP1003777B1 PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | EP0811073B1 Use of immune modulators for making medicaments ot inhibit immune responses against co-administered recombinant viruses |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 01/24/2007 | EP0749321B1 Active immunization using a siderophore receptor protein |
| 01/24/2007 | CN1902314A Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 01/24/2007 | CN1902312A Method of constructing transgenic dendritic cell |
| 01/24/2007 | CN1902231A CD20 antibodies with increased Fc receptor binding affinity and effector function |
| 01/24/2007 | CN1902229A IL-18 binding proteins |
| 01/24/2007 | CN1902221A Neutralizing epitope-based growth enhancing vaccine |
| 01/24/2007 | CN1901937A Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 01/24/2007 | CN1901936A Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 01/24/2007 | CN1901935A Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 01/24/2007 | CN1901930A Integrin alphaiibbeta3 specific antibodies and peptides |
| 01/24/2007 | CN1901925A Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
| 01/24/2007 | CN1901839A Soluble TCR molecules and methods of use |
| 01/24/2007 | CN1900320A Diagnostic assay |
| 01/24/2007 | CN1900303A Process for preparing plant immune globulin and its use |
| 01/24/2007 | CN1900119A Staphylococcus aureus enterotoxin 1 and preparation and use |
| 01/24/2007 | CN1900118A No-adjuvant therapeutic protein vaccine containing heat shock protein and HPV 16Z protein antigen |
| 01/24/2007 | CN1900117A Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin |
| 01/24/2007 | CN1900116A Anti-lymphotoxin-beta receptor antibodies, pharmaceutical composition containing the same and pharmaceutical application thereof |
| 01/24/2007 | CN1900113A Tumor relative polypeptide and its coding gene sequence |
| 01/24/2007 | CN1900111A Recombinant tubercle bacillus antigen poly epitope peptide and its constructing method and use |
| 01/24/2007 | CN1899613A Therapeutic polypeptide hepatitis B vaccine and its preparing method and using method |
| 01/24/2007 | CN1899612A Therapeutical peptide hepatitis C vaccine and its preparing method |
| 01/24/2007 | CN1899611A Therapeutical polypeptide hepatitis B vaccine and its preparing method |
| 01/24/2007 | CN1899610A Pyloric spiral bacillus antigen recombinant vaccine |
| 01/24/2007 | CN1899609A Pneumococcus polysaccharide protein coupling vaccine and its preparing method |
| 01/24/2007 | CN1899608A Vaccine for preventing and treating aspergillin infection and its preparing method |
| 01/24/2007 | CN1899607A Double effect tumor cell vaccine and its preparing method |
| 01/24/2007 | CN1899308A Method for producing immunological milk containing specific antibody |
| 01/24/2007 | CN1296386C Use of CD 25 binding molecules in steroid-resistant patients |
| 01/24/2007 | CN1296096C Poxvirus-containing formulations and process for preparing stable, poxvirus containing compositions |
| 01/24/2007 | CN1296095C Improved mycoplasma hyopneumoniae bacterin vaccine |
| 01/23/2007 | US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer |
| 01/23/2007 | US7166712 A cDNA encoding a mammalian MDM2 binding protein for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166700 PRO703 Polypeptides |
| 01/23/2007 | US7166697 V-like domain binding molecules |
| 01/23/2007 | US7166694 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |